Health Sciences
Resources
Basic InformationMore InformationLatest News
Stimulant Normalizes Brain Activation in Youth With ADHDDocs Use 3-D Printer to Create Lifesaving Airway Device for InfantChildren Who Have CT Scans May Face Higher Cancer RiskCellphone Use May Reveal Your 'Dominant Brain'Test Approved to Detect Faulty Lung Cancer GeneScientists Use Cloning Technique to Produce Human Stem CellsCognitive Health Info From Doctors Found to Be LackingDaily Gene Rhythms May Be Off in Depressed PeopleGene Discovery May Offer Breakthrough for Rare LeukemiaEating Peppers Tied to Lower Parkinson's Risk, Study FindsRed Hair Pigment Might Raise Melanoma Risk: StudyMuhammad Ali's Daughter Champions Fight Against Parkinson's Disease'What's Bad for the Heart Also Bad for the Brain'Bipolar Disorder Drugs May 'Tweak' Genes Affecting BrainGene Studies Could Point to New Alzheimer's Treatments'Off-the-Shelf' Artificial Blood Vessels Show PromiseU.S. Shortfall in Neurologists Expected to Get WorseBrain Stimulation Reduces Smoking CravingsShrinkage of Brain Region May Signal Onset of Multiple SclerosisGenetics Linked to Abnormal Alzheimer's MarkersVascular Markers Linked to Cognitive Decline in DiabetesScientists May Have Spotted Brain's 'Numbers Center'Brain Changes Seen in Relatives of People With Alzheimer'sAerobic Exercise Reduces Brain Damage From Alcohol10 Years On, Still Much To Be Learned From Human Genome MapStem Cells to Relieve Low Back Pain?Study Links Stillbirth to Genes Tied to Dangerous Heart RhythmWeight-Loss Surgery May Affect Fat-Related GenesFor First Time, Pain 'Signature' Spotted on Brain MRIs'Transparent' Mouse Brain Could Shed Light on Human Brain HealthGene May Double Risk of Alzheimer's in BlacksStudy Locates More Obesity GenesScans May Reveal Pre-Schizophrenia Brain ChangesObama Administration Unveils The BRAIN InitiativeBrain Differences Seen in People With MigrainesEarly Thinking Problems May Signal Future Dementia in Parkinson's PatientsBrain Changes Could Contribute to Gulf War Illness: StudyGenetics May Be Tied to Breast Cancer Risk in Unexpected WaysTelemedicine Is Useful for Parkinson's Disease PatientsAAN: Three New Treatments Show Promise for Parkinson'sCirculating Tumor DNA Is Key Clue to Breast Cancer SpreadNew Drugs May Offer Hope to Parkinson's PatientsScientists ID Antibody That Might Boost Cancer TherapyProcedure Lowers 'Hunger Hormone' to Help Obese Lose WeightBrain 'Pacemaker' May Help Ease Tough-to-Treat AnorexiaBrain Scans May Explain Thinking, Memory Problems in Some MS PatientsEye-Tracking Tool Might Quickly Spot StrokeSNPs Confer Risk for Multiple Psychiatric DisordersShared Genes May Link ADHD, Autism and DepressionGene Disorder Screen Benefits Baby Boys, Girls Equally: Study
Questions and AnswersLinksBook Reviews
Related Topics

Medical Disorders
Mental Disorders
Mental Health Professions

Genes Might Help Some Smokers Kick the Habit

HealthDay News
by -- Robert Preidt
Updated: May 31st 2012

new article illustration

THURSDAY, May 31 (HealthDay News) -- Smokers' genes may help predict whether they'll respond to drug treatments for nicotine addiction, a new study indicates.

Researchers analyzed data from more than 6,000 smokers in community-based studies and a clinical treatment study and found that the same gene variations that make it difficult to stop smoking also increase the chances that heavy smokers will respond to nicotine-replacement therapy and drugs that reduce the craving for nicotine.

"People with the high-risk genetic markers smoked an average of two years longer than those without these high-risk genes, and they were less likely to quit smoking without medication," study first author Dr. Li-Shiun Chen, an assistant professor of psychiatry at Washington University of Medicine in St. Louis, said in a university news release.

"The same gene variants can predict a person's response to smoking-cessation medication, and those with the high-risk genes are more likely to respond to the medication," Chen said.

In the clinical treatment study, smokers with the high-risk variants were three times more likely than those without the variants to respond to treatments such as nicotine gum, nicotine patches, the antidepressant bupropion (Wellbutrin is one brand) and other drugs used to help people stop smoking.

The findings, published online May 30 in the American Journal of Psychiatry, suggest it may eventually be possible to analyze smokers' genes in order to predict if they'll benefit from drug treatments for nicotine addiction.

"Smokers whose genetic makeup puts them at the greatest risk for heavy smoking, nicotine addiction and problems kicking the habit also appear to be the same people who respond most robustly to pharmacologic therapy for smoking cessation," senior investigator Dr. Laura Jean Bierut, a professor of psychiatry, said in the news release.

The gene variants in this study aren't the only ones involved in whether a person smokes, becomes addicted or has difficulty quitting, but they are an important part of the overall nicotine-addiction puzzle, the researchers said.

"These variants make a very modest contribution to the development of nicotine addiction, but they have a much greater effect on the response to treatment," Bierut said. "That's a huge finding."

More information

The American Cancer Society offers a guide to quitting smoking.

This article: Copyright © 2012 HealthDay. All rights reserved.